Android app on Google Play

Guggenheim Starts Merrimack Pharmaceuticals (MACK) at Buy

November 9, 2012 9:47 AM EST Send to a Friend
Get Alerts MACK Hot Sheet
Price: $7.02 +0.57%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 13 | New: 52
Trade MACK Now!
Join SI Premium – FREE
Guggenheim initiates coverage on Merrimack Pharmaceuticals (NASDAQ: MACK) with a Buy. PT $13.00.

For an analyst ratings summary and ratings history on Merrimack Pharmaceuticals click here. For more ratings news on Merrimack Pharmaceuticals click here.

Shares of Merrimack Pharmaceuticals closed at $6.84 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment